Evidence, Interpretation, and Qualification From Multiple Reports of Long- Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA), Part I: Executive Summary
Creators:
Swanson, JamesArnold, L. Eugene
Kraemer, Helena
Hechtman, Lily
Molina, Brooke
Hinshaw, Stephen
Vitiello, Benedetto
Jensen, Peter
Steinhoff, Ken
Lerner, Marc
Greenhill, Laurence
Abikoff, Howard
Wells, Karen
Epstein, Jeffery
Elliott, Glen
Newcorn, Jeffrey
Hoza, Betsy
Wigal, Timothy
Issue Date:
2008Metadata
Show full item recordPublisher:
Sage Publications Ltd.Citation:
James Swanson et al, "Evidence, Interpretation, and Qualification From Multiple Reports of Long- Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA), Part I: Executive Summary," Journal of Attention Disorders 12, no. 1 (2008), doi:10.1177/1087054708319345Abstract:
Objective:
To review the primary and secondary findings from the Multimodal Treatment study of ADHD
(MTA) published over the past decade as three sets of articles.
Method:
In a two-part article—Part I: Executive Summary (without distracting details) and Part II:
Supporting Details (with additional background and detail required by the complexity of the MTA)—we
address confusion and controversy about the findings.
Results:
We discuss the basic features of the gold standard used to produce scientific evidence, the
randomized clinical trial, for which was used to contrast four treatment conditions: medication management
alone (MedMgt), behavior therapy alone (Beh), the combination of these two (Comb), and a community
comparison of treatment “as usual” (CC). For each of the three assessment points we review three areas
that we believe are important for appreciation of the findings: definition of evidence from the MTA,
interpretation of the serial presentations of findings at each assessment point with a different definition of
long-term, and qualification of the interim conclusions about long-term effects of treatments for ADHD.
Conclusion:
We discuss the possible clinical relevance of the MTA and present some practical suggestions
based on current knowledge and uncertainties facing families, clinicians, and investigators regarding the
long-term use of stimulant medication and behavioral therapy in the treatment of children with ADHD. (J.
of Att. Dis. 2008; 12(1) 4-14)
Type:
ArticleISSN:
1087-0547Rights:
© 2008 Sage Publications Ltd.Collections
Items in Knowledge Bank are protected by copyright, with all rights reserved, unless otherwise indicated.